Per Løgstrup Poulsen

Clinical Professor

Aarhus Universitet Health

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Per Løgstrup Poulsen is a Clinical Professor at Aarhus Universitet Health in Denmark. His research primarily focuses on the effects of various treatments and interventions for patients with type 2 diabetes, emphasizing the role of medications such as colchicine and semaglutide. Recent publications include studies on platelet aggregation, arterial stiffness, and renal health in this patient population.

Articles (11)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (11)

Henrik Birn

Professor

Aarhus Universitet Health

DENMARK

View details

Toke Bek

Aarhus University

DENMARK

View details

Esben Søndergaard

Aarhus University Hospital

DENMARK

View details

Morten Madsen

Aarhus University

DENMARK

View details

Christoffer Laustsen

Professor

Aarhus University

DENMARK

View details

Kristian Løkke Funck

Aarhus University

DENMARK

View details

Kirstine Stochholm

Aarhus University Hospital

DENMARK

View details

Lars Rolighed

Aarhus University Hospital

DENMARK

View details

Jens Otto Lunde Jørgensen

Aarhus University Hospital

DENMARK

View details

Andreas Ebbehøj

Aarhus University

DENMARK

View details

Lars Poulsen Tolbod

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Per Løgstrup Poulsen

Research Interests

Contact this professor

About

Articles (11)

Semaglutide, central retinal thickness and continuous glucose monitoring in persons with type 2 diabetes

Test-retest repeatability of quantitative organ and tissue uptake using 20-minute dynamic multiparametric whole-body [18F]FDG PET/CT in patients with type 2 diabetes

Effect of colchicine on platelet aggregation in patients with type 2 diabetes: Results from a randomized placebo-controlled trial

Colchicine mitigates arterial stiffness in high-risk patients with type 2 diabetes: A randomized placebo-controlled trial

The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial

Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial

Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial

Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial

The socio-economic consequences of Cushing's syndrome

Outcome and prognosis after adrenal metastasectomy: nationwide study

Collaborators (11)

Henrik Birn

Toke Bek

Esben Søndergaard

Morten Madsen

Christoffer Laustsen

Kristian Løkke Funck

Kirstine Stochholm

Lars Rolighed

Jens Otto Lunde Jørgensen

Andreas Ebbehøj

Lars Poulsen Tolbod

Make your next move.